2 Result: NYSE:AMPX
Buy-Rated: AMPX, RIVN, FDMT, CBAY, HTZ, PED - Unlocking Upside Potential
July 05th, 2023
Amprius Technologies, Inc. (NYSE: AMPX), a leading provider of advanced lithium-ion battery technology, was assumed by EF Hutton with a Buy rating and a price target of $14. With $AMPX closing at $6.98 on Monday, the assigned price target suggests. Read more
NewAmsterdam, Acrivon, Veeva Systems, Amprius Technologies: Latest Updates, Potential Upsides
June 04th, 2023
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) released the comprehensive findings from the ROSE2 Phase 2 clinical trial, which examined the efficacy of obicetrapib, their oral, low-dose cholesteryl ester transfer protein inhibitor, in conjunction w. Read more
Want To Find Some News?
News By Industries
Recent Post
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026
Member Login